Your browser doesn't support javascript.
loading
eIF3 mRNA selectivity profiling reveals eIF3k as a cancer-relevant regulator of ribosome content.
Duan, Haoran; Zhang, Siqiong; Zarai, Yoram; Öllinger, Rupert; Wu, Yanmeng; Sun, Li; Hu, Cheng; He, Yaohui; Tian, Guiyou; Rad, Roland; Kong, Xiangquan; Cheng, Yabin; Tuller, Tamir; Wolf, Dieter A.
Afiliação
  • Duan H; State Key Laboratory of Stress Biology and Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
  • Zhang S; State Key Laboratory of Stress Biology and Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
  • Zarai Y; Department of Biomedical Engineering, Tel Aviv University, Tel Aviv, Israel.
  • Öllinger R; Institute of Molecular Oncology and Functional Genomics and Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.
  • Wu Y; State Key Laboratory of Stress Biology and Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
  • Sun L; State Key Laboratory of Stress Biology and Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
  • Hu C; State Key Laboratory of Stress Biology and Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
  • He Y; State Key Laboratory of Stress Biology and Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
  • Tian G; State Key Laboratory of Stress Biology and Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
  • Rad R; Institute of Molecular Oncology and Functional Genomics and Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.
  • Kong X; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cheng Y; Department of Internal Medicine II, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
  • Tuller T; Department of Radiation Oncology, Xiamen Humanity Hospital, Fujian Medical University, Xiamen, China.
  • Wolf DA; State Key Laboratory of Stress Biology and Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
EMBO J ; 42(12): e112362, 2023 06 15.
Article em En | MEDLINE | ID: mdl-37155573
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Iniciação 3 em Eucariotos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: EMBO J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Iniciação 3 em Eucariotos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: EMBO J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China